https://parkinsons-therapeutics.org/about/2023-07-13T03:24:23+00:00weekly0.6https://parkinsons-therapeutics.org/other-resources/2021-09-24T04:19:34+00:00weekly0.6https://parkinsons-therapeutics.org/therapeutic-options/2019-11-14T16:54:44+00:00weekly0.6https://parkinsons-therapeutics.org/advanced-levodopa-pharmacokinetics/https://parkinsons-therapeutics.org/wp-content/uploads/2019/05/eq1.pngeq1https://parkinsons-therapeutics.org/wp-content/uploads/2019/05/eq2.pngeq2https://parkinsons-therapeutics.org/wp-content/uploads/2019/05/pk-calc.pngPK-calc2019-11-14T16:52:03+00:00weekly0.6https://parkinsons-therapeutics.org/does-dietary-protein-reduce-levodopa-absorption/2019-11-11T02:33:23+00:00weekly0.6https://parkinsons-therapeutics.org/pharmd/2019-11-08T22:02:50+00:00weekly0.6https://parkinsons-therapeutics.org/do-chemicals-cause-parkinsons-disease/https://parkinsons-therapeutics.org/wp-content/uploads/2018/04/paraquat.pngParaquatParaquathttps://parkinsons-therapeutics.org/wp-content/uploads/2018/04/640px-rotenone_structural_formula_v-1-svg.png640px-Rotenone_Structural_Formula_V.1.svgRotenonehttps://parkinsons-therapeutics.org/wp-content/uploads/2018/04/500px-mpp.png500px-MPP+MPP+2019-05-06T05:52:48+00:00weekly0.6https://parkinsons-therapeutics.org/is-levodopa-toxic/https://parkinsons-therapeutics.org/wp-content/uploads/2015/11/elldopa.pngELLDOPA2019-05-06T05:30:48+00:00weekly0.6https://parkinsons-therapeutics.org/why-do-i-have-to-take-levodopa-so-frequently/https://parkinsons-therapeutics.org/wp-content/uploads/2015/10/entacapone2dacs-svg.pngEntacapone2DACS.svghttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/dopa-pk-compare.pngDOPA-PK-comparehttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/duopa-trial-pk.pngDUOPA-trial-PKhttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/dopa-pk.jpgdopa-pk2019-01-12T04:49:46+00:00weekly0.6https://parkinsons-therapeutics.org/other-therapeutic-options/https://parkinsons-therapeutics.org/wp-content/uploads/2017/04/traffic-light-yellow-dan-01-800px.pngtraffic-light-yellow-dan-01-800pxhttps://parkinsons-therapeutics.org/wp-content/uploads/2017/04/traffic-light-red-dan-ge-01-800px.pngtraffic-light-red-dan-ge-01-800pxhttps://parkinsons-therapeutics.org/wp-content/uploads/2017/04/traffic-light-green-dan-01-800px.pngtraffic-light-green-dan--01-800px2019-01-12T04:38:32+00:00weekly0.6https://parkinsons-therapeutics.org/nuplazid-pimavanserin/https://parkinsons-therapeutics.org/wp-content/uploads/2018/04/pimavanserin.pngPimavanserinPimavanserinhttps://parkinsons-therapeutics.org/wp-content/uploads/2016/06/nuplazid2.pngnuplazid2https://parkinsons-therapeutics.org/wp-content/uploads/2016/06/nuplazid1.pngnuplazid12018-04-29T01:48:53+00:00weekly0.6https://parkinsons-therapeutics.org/physiological-basis-of-parkinsons/2018-04-23T20:55:45+00:00weekly0.6https://parkinsons-therapeutics.org/is-parkinsons-disease-genetic/https://parkinsons-therapeutics.org/wp-content/uploads/2016/01/mitophagy.jpgmitophagy2018-04-23T02:13:23+00:00weekly0.6https://parkinsons-therapeutics.org/do-you-die-from-parkinsons/https://parkinsons-therapeutics.org/wp-content/uploads/2015/12/pd-death-rate1-replotted.pngpd-death-rate1-replotted2018-04-23T02:07:13+00:00weekly0.6https://parkinsons-therapeutics.org/if-genetics-and-toxins-only-account-for-a-small-fraction-of-parkinsons-cases-then-what-causes-the-rest/2018-04-23T02:05:31+00:00weekly0.6https://parkinsons-therapeutics.org/what-happens-to-dopamine-after-it-is-made/https://parkinsons-therapeutics.org/wp-content/uploads/2015/10/neuromelanin.pngneuromelaninhttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/200px-eumelanine-svg.png200px-Eumelanine.svghttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/dopa-quinone.pngdopa-quinonehttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/440px-dopamine_degradation-svg.png440px-Dopamine_degradation.svg2018-04-23T02:00:46+00:00weekly0.6https://parkinsons-therapeutics.org/why-do-the-dopamine-producing-cells-die/https://parkinsons-therapeutics.org/wp-content/uploads/2015/10/400px-mptp-svg.png400px-MPTP.svgMPTP2018-04-23T01:57:46+00:00weekly0.6https://parkinsons-therapeutics.org/is-parkinsons-one-disease/2018-04-23T01:55:45+00:00weekly0.6https://parkinsons-therapeutics.org/where-does-dopamine-come-from/https://parkinsons-therapeutics.org/wp-content/uploads/2015/10/image3.jpgimagehttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/image2.jpgimagehttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/image1.jpgimage2018-04-23T01:49:37+00:00weekly0.6https://parkinsons-therapeutics.org/amantadine/https://parkinsons-therapeutics.org/wp-content/uploads/2018/04/amantadine-e1524434480335.pngAmantadineAmantadine2018-04-22T22:59:25+00:00weekly0.6https://parkinsons-therapeutics.org/is-a-cure-imminent/2018-04-22T21:47:35+00:00weekly0.6https://parkinsons-therapeutics.org/droxidopa-northera/https://parkinsons-therapeutics.org/wp-content/uploads/2017/04/droxidopa-clinical-trial.pngdroxidopa-clinical-trialhttps://parkinsons-therapeutics.org/wp-content/uploads/2017/04/chemical-analogy-droxidopa.pngchemical analogy (droxidopa)2018-04-22T21:45:26+00:00weekly0.6https://parkinsons-therapeutics.org/intro-to-dopamine-agonists/https://parkinsons-therapeutics.org/wp-content/uploads/2016/04/dopamine-agonists.pngdopamine agonists2018-04-22T21:41:49+00:00weekly0.6https://parkinsons-therapeutics.org/does-rasagiline-azilect-delay-disease-progression/https://parkinsons-therapeutics.org/wp-content/uploads/2015/11/rasagiline-2mg.pngrasagiline-2mghttps://parkinsons-therapeutics.org/wp-content/uploads/2015/11/rasagiline-1mg.pngrasagiline-1mg2018-04-22T21:36:53+00:00weekly0.6https://parkinsons-therapeutics.org/mao-b-inhibitors/https://parkinsons-therapeutics.org/wp-content/uploads/2015/11/rasagiline2dcsd-svg.pngRasagiline2DCSD.svghttps://parkinsons-therapeutics.org/wp-content/uploads/2015/11/400px-tyramine-svg.png400px-Tyramine.svghttps://parkinsons-therapeutics.org/wp-content/uploads/2015/11/levomethamphetamine-svg.pngLevomethamphetamine.svghttps://parkinsons-therapeutics.org/wp-content/uploads/2015/11/selegiline2dcsd-svg.pngSelegiline2DCSD.svg2018-04-22T21:35:27+00:00weekly0.6https://parkinsons-therapeutics.org/levodopa-side-effects-dyskinesia/https://parkinsons-therapeutics.org/wp-content/uploads/2018/04/dyskinesia.jpgdyskinesiaMany patients experience dyskinesia when levodopa levels peak, shortly after taking a levodopa-containing pill ("peak-dose dyskinesia", red); others experience "diphasic" dyskinesias, which occur when levodopa levodopa levels are changing rapidly (green). Open source image gratefully acknowledged, taken from https://www.ncbi.nlm.nih.gov/pubmed/23125942.2018-04-22T21:29:28+00:00weekly0.6https://parkinsons-therapeutics.org/fear-of-levodopa-does-it-stop-working/2018-04-22T21:19:13+00:00weekly0.6https://parkinsons-therapeutics.org/are-there-natural-sources-of-l-dopa/https://parkinsons-therapeutics.org/wp-content/uploads/2015/10/580px-34-dihydroxy-l-phenylalanin_levodopa-svg.png580px-3,4-Dihydroxy-L-phenylalanin_(Levodopa).svg2018-04-22T21:13:49+00:00weekly0.6https://parkinsons-therapeutics.org/basics-of-levodopa/https://parkinsons-therapeutics.org/wp-content/uploads/2015/11/tyrosine-to-dopamine.pngtyrosine-to-dopaminehttps://parkinsons-therapeutics.org/wp-content/uploads/2015/11/dopa-to-dopamine.pngdopa-to-dopamine2018-04-22T20:31:35+00:00weekly0.6https://parkinsons-therapeutics.org/safinamide/https://parkinsons-therapeutics.org/wp-content/uploads/2017/04/safinamide-clinical-trial.pngsafinamide-clinical trialhttps://parkinsons-therapeutics.org/wp-content/uploads/2017/04/safinamide.pngSafinamide2017-04-11T05:19:46+00:00weekly0.6https://parkinsons-therapeutics.org/all-about-dopamine/https://parkinsons-therapeutics.org/wp-content/uploads/2015/10/blausen_0704_parkinsonsdisease.pngBlausen_0704_ParkinsonsDiseasehttps://parkinsons-therapeutics.org/wp-content/uploads/2015/10/image.jpgimage2016-04-26T02:50:53+00:00weekly0.6https://parkinsons-therapeutics.org/imagining-the-cure/2015-12-14T16:49:17+00:00weekly0.6https://parkinsons-therapeutics.org/why-do-men-get-parkinsons-more-than-women/2015-11-24T04:36:30+00:00weekly0.6https://parkinsons-therapeutics.org/the-basics-of-parkinsons-disease/2015-10-17T04:39:04+00:00weekly0.6https://parkinsons-therapeutics.orgdaily1.02023-07-13T03:24:23+00:00